Psyence Other Cashflows From Financing Activities from 2010 to 2024

PBMWW Stock   0.01  0  16.00%   
Psyence Biomedical Other Cashflows From Financing Activities yearly trend continues to be fairly stable with very little volatility. Other Cashflows From Financing Activities will likely drop to -6,013 in 2024. During the period from 2010 to 2024, Psyence Biomedical Other Cashflows From Financing Activities regression line of quarterly data had mean square error of 482.4 B and geometric mean of  752,178. View All Fundamentals
 
Other Cashflows From Financing Activities  
First Reported
2010-12-31
Previous Quarter
-5.7 K
Current Value
-6 K
Quarterly Volatility
872.9 K
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Psyence Biomedical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Psyence Biomedical's main balance sheet or income statement drivers, such as Interest Income of 1.4 K, Selling General Administrative of 1.8 M or Selling And Marketing Expenses of 84.6 K, as well as many indicators such as Price To Sales Ratio of 0.0, Ptb Ratio of 0.0 or Days Sales Outstanding of 0.0. Psyence financial statements analysis is a perfect complement when working with Psyence Biomedical Valuation or Volatility modules.
  
Check out the analysis of Psyence Biomedical Correlation against competitors.

Latest Psyence Biomedical's Other Cashflows From Financing Activities Growth Pattern

Below is the plot of the Other Cashflows From Financing Activities of Psyence Biomedical Ltd over the last few years. It is Psyence Biomedical's Other Cashflows From Financing Activities historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Psyence Biomedical's overall financial position and show how it may be relating to other accounts over time.
Other Cashflows From Financing Activities10 Years Trend
Slightly volatile
   Other Cashflows From Financing Activities   
       Timeline  

Psyence Other Cashflows From Financing Activities Regression Statistics

Arithmetic Mean(1,224,649)
Geometric Mean752,178
Coefficient Of Variation(71.28)
Mean Deviation644,684
Median(1,627,576)
Standard Deviation872,902
Sample Variance762B
Range2.8M
R-Value0.64
Mean Square Error482.4B
R-Squared0.41
Significance0.01
Slope125,302
Total Sum of Squares10.7T

Psyence Other Cashflows From Financing Activities History

2024 -6013.35
2023 -5727.0
20221.2 M

About Psyence Biomedical Financial Statements

Psyence Biomedical investors use historical fundamental indicators, such as Psyence Biomedical's Other Cashflows From Financing Activities, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Psyence Biomedical. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Other Cashflows From Financing Activities-5.7 K-6 K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Psyence Stock Analysis

When running Psyence Biomedical's price analysis, check to measure Psyence Biomedical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Psyence Biomedical is operating at the current time. Most of Psyence Biomedical's value examination focuses on studying past and present price action to predict the probability of Psyence Biomedical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Psyence Biomedical's price. Additionally, you may evaluate how the addition of Psyence Biomedical to your portfolios can decrease your overall portfolio volatility.